Abstract
Background
The care and outcome of enterocutaneous fistula (ECF) have improved greatly over several decades due to revolutionary advances in nutrition, along with dramatic improvements in the treatment of sepsis and the critically ill. However, as the collective experience with damage control surgery has matured, the frequent development of enteroatmospheric fistula (EAF) in the “open abdomen” patient has emerged as an even more vexing problem. Despite our best efforts, ECF and especially EAF continue to be highly morbid conditions, and sepsis and malnutrition remain the leading causes of death. Aggressive nutritional and metabolic support is the most significant predictor of outcome with ECF and EAF.
Results
Discussion of the historical advances in nutritional therapy and their impact on ECF, as well as review of the classification of ECF and EAF, provides a framework for the suggested phased strategy that specifically targets the nutritional and metabolic needs of the ECF/EAF patient. These three phases include (1) diagnosis, resuscitation, and early interval nutrition; (2) definition of fistula anatomy, drainage of collections, nutritional assessment and monitoring, and placement of feeding access; and (3) definitive nutritional management, including pharmacologic adjuncts. Early nutritional support with parenteral nutrition followed by transition to enteral nutrition is advocated, including the merits of delivery of enteral nutrition via the fistula itself, known as fistuloclysis.
Conclusion
Aggressive nutritional therapy is necessary to reverse the catabolic state associated with ECF/EAF patients. Once established, it allows proper time, preparation, and planning for definitive management of the fistula, and in many cases provides the support for spontaneous closure.
Similar content being viewed by others
References
Bhishagratna KK (trans) (1907) An English translation of The Sushruta Samhita: based on original Sanskrit text. Wilkens Press, Calcutta. Available at http://www.archive.org/stream/englishtranslati01susruoft#page/n23/mode/2up/search/ant Accessed 1 Feb 2011
Sarr MG, Bass P, Woodward E (1991) The famous gastrocutaneous fistula of Alexis st. Martin—Why didn’t it close? Or should we refer to it as a gastric stoma? Dig Dis Sci 36(10):1345–1347
Colp R (1923) External duodenal fistulae. Ann Surg 78:725–744
Edmunds LH, Williams GM, Welch CE (1960) External fistulas arising from the gastro-intestinal tract. Ann Surg 152:445–471
Chapman R, Foran R et al (1964) Management of intestinal fistula. Am J Surg 108:974–984
Lundy JB, Fischer JE (2010) Historical perspectives in the care of patients with enterocutaneous fistula. Clin Colon Rectal Surg 23:133–141
Hull HC, Barnes TG (1951) Total intravenous alimentation in the treatment of small bowel fistulas. Ann Surg 133(5):644–650
Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE (1969) Can intravenous feeding as the sole means of nutrition support growth in the child and restore weight loss in an adult? An affirmative answer. Ann Surg 169:974–984
Schecter WP, Hirshberg A, Chang DS et al (2009) Enteric fistula: principles of management. J Am Coll Surg 209(4):484–491
Arebi N, Forbes A (2004) High output fistulas. Clin Colon Rectal Surg 17(2):89–98
Fenves AZ, Emmett M (1996) Fluid and electrolytes. In: O’Leary JP (ed) The physiologic basis of surgery, 2nd edn. Williams and Willams, Baltimore
Berry SM, Fischer JE (1996) Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am 76:1009–1018
Rotondo MF, Schwab CW, McGonigal MD et al (1983) Damage control: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 35(3):375–383
Jacobs S, Price Evans DA et al (2003) Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 31:1938–1946
Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 36:296–327 Erratum 36:1394–1396
Lee JK, Stein SL (2010) Radiographic and endoscopic diagnosis and treatment of enterocutaneous fistulas. Clin Colon Rectal Surg 23:149–160
Dudrick SJ, Maharaj AR, McKelvey AA (1999) Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 23:570–576. doi:10.1007/PL00012349
Williams LJ, Zolfaghari S, Boushey RP (2010) Complications of enterocutaneous fistulas and their management. Clin Colon Rectal Surg 23:209–220
Hoedema RE, Suryadevara S (2010) Enterostomal therapy and wound care of the enterocutaneous fistula patient. Clin Colon Rectal Surg 23:161–168
Evenson AR, Fischer JE (2006) Current management of enterocutaneous fistula. J Gastrointestinal Surg 10(3):455–464
Cheatham ML, Safcsak K, Brzezinski SJ et al (2007) Nitrogen balance, protein loss, and the open abdomen. Crit Care Med 35(1):127–131
Nutrition Advisory Committee (1997) Clinical nutrition: a resource book for delivering enteral and parenteral nutrition for adults, University of Washington Medical Center and Harborview Medical Center, Seattle. Available at http://healthlinks.washington.edu/nutrition/section7.html Accessed 6 Apr 2011
Gibbs J, Cull W, Henderson W et al (1999) Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 134:36–42
Fazio VS, Coutsoftides T, Stieger E (1983) Factors influencing outcome of treatment of small bowel cutaneous fistula. World J Surg 7:481–488. doi:10.1007/BF01655937
Lu CY, Wu DC, Wu IC (2008) Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients. J Invest Surg 21:25–32
Kuvshinoff BW, Brodish RJ, McFadden DW et al (1993) Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal fistula. Ann Surg 217(6):615–622
Lubana PS, Aggarwal G, Aggarwal H et al (2010) Serum transferrin levels—a predictive marker of spontaneous closure and mortality in patients with enterocutaneous fistulae. Arab J Gastroenterol 11:212–214
Bleir JI, Hedrick T (2010) Metabolic support of the enterocutaneous fistula patient. Clin Colon Rectal Surg 23:142–148
MacFadyen BV, Dudrick SJ, Ruberg RI (1973) Management of gastrointestinal fistula with parenteral hyperalimentation. Surgery 74(1):100–105
Himal HS, Allard JR, Nadea JE et al (1974) The importance of adequate nutrition in closure of small intestinal fistulas. Br J Surg 61:724–730
Deitel M (1976) Nutritional management of external gastrointestinal fistulas. Can J Surg 19:505–509
Tilson MD (1980) Pathophysiology of short bowel syndrome. Surg Clin North Am 60:1273–1284
Lloyd DA, Gabe SM, Windsor AC (2006) Nutrition and management of enterocutaneous fistula. Brit J Surg 93:1045–1055
Dardai E, Pirityi SZ, Nagy L (1991) Parenteral and enteral nutrition and the enterocutaneous fistula treatment II: factors influencing the outcome of patients. Acta Chir Hung 32(4):305–318
Levy E, Fileux P, Cugnenc PH et al (1989) High output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 76:676–679
Li J, Ren J, Zhu W et al (2003) Management of enterocutaneous fistulas: 30-year clinical experience. Chin Med J 116(2):171–175
Teubner A, Morrison K, Ravishankar et al (2004) Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 91:625–631
McClave SA, Martindale RG, Vanek VW (2009) Guidelines for the provision of nutrition support therapy in the adult critically ill patient: Society for Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N). JPEN J Parenter Enteral Nutr 33:277–316
Collier B, Guillamondegui O, Cotton B et al (2007) Feeding the open abdomen. JPEN J Parenter Enteral Nutr 31(5):410–415
Dissanaike S, Pham T, Shalhub S et al (2008) Effect of immediate enteral feeding on trauma patients with an open abdomen: protection from nosocomial infection. J Am Coll Surg 207(5):690–697
Levy EP, Palmer DL, Frileaux P et al (1983) Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel: a clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 198(5):596–600
Slater R (2009) Nutritional management of enterocutaneous fistula. Br J Nurs 18(4):225–230
Cresci GA, Martindale RG (1997) Metabolic and nutritional management of a patient with multiple enterocutaneous fistulas. Nutrition 13:446–449
Mettu SR (2004) Correspondence: fistuloclysis can replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 91(9):1203
Farrer K, Teubner A (2003) Fistuloclysis-distal feeding handbook: information and guidance for patients and healthcare professionals. Salford Royal Hospital, Manchester
Subramaniam MH, Liscum KR, Hirshberg A (2002) The floating stoma: a new technique for controlling exposed fistulae in abdominal trauma. J Trauma 53:386–388
Cawich SO, McFarlane ME, Mitchell DI (2007) Fistuloclysis: cost effective nutrition for patients with enterocutaneous fistulae. Internet J Third World Med 4(2)
Bury KD, Stephens RV, Randal HT (1971) Use of chemically defined, liquid, elemental diet for nutritional management of fistulas of the alimentary tract. Am J Surg 121(2):174–183
Heys SD, Walker LG, Smith I, Eremin O (1999) Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 229:467–477
Beale RJ, Bryg DJ, Bihari DJ (1999) Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 27:2799–2805
Martindale RG, Cresci GA (2001) The use of immune enhancing diet in head injury. JPEN J Parenter Enteral Nutr 25(2 Suppl):S27–S28
Cerra FB, Lehman S, Konstantinides N, Konstantinides F, Shronts EP, Holman R (1990) Effect of enteral nutrient on in vitro tests of immune function in ICU patients: a preliminary report. Nutrition 6:84–87
Gottschlich MM, Jenkins M, Warden GD et al (1990) Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr 14:225–236
King RF, Norton T, Hill GI (1982) A double-blinded crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust NZ J Surg 52(2):121–124
Nubiola P, Badia JM, Martinez-Rodenas F et al (1989) Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201–995. Ann Surg 210:56–58
Barnes SM, Kontny BG, Prinz RA (1993) Somatostatin analog treatment of pancreatic fistulas. Int J Pancreatol 14:181–188
Nubiola-Calonge P, Badia JM, Sancho J, Gil MJ, Segura M, Sitges-Serra A (1987) Blind evaluation of the effect of octreotide (SMS 201–995), a somatostatin analogue, on small-bowel fistula output. Lancet 2:672–674
Hernandez-Aranda JC, Gallo-Chico B, Flores-Ramirez LA, Avalos-Huante R, Magos-Vazquez FJ, Ramirez-Barba EJ (1996) Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition. Nutr Hosp 11:226–229
Cooper AM, Braatvedt GD, Brown H et al (1991) Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci (London) 81(2):169–175
Heuser M, Popken O, Kleiman I, Post S (2000) Detrimental effects of octreotide on intestinal microcirculation. J Surg Res 92(2):186–192
Kacmaz A, Polat A, User Y et al (2004) Octreotide improves reperfusion-induced oxidative injury in acute abdominal hypertension in rats. J Gastroint Surg 8(1):113–119
Morris JB, Guerrero NH, Furth EE, Stellato TA (1993) Somatostatin attenuates ischemic intestinal injury. Am J Surg 165(6):676–680
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Polk, T.M., Schwab, C.W. Metabolic and Nutritional Support of the Enterocutaneous Fistula Patient: A Three-Phase Approach. World J Surg 36, 524–533 (2012). https://doi.org/10.1007/s00268-011-1315-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-011-1315-0